GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 204,100 shares of the company’s stock after selling 2,848 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in GE HealthCare Technologies were worth $15,957,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. CoreFirst Bank & Trust acquired a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. acquired a new position in GE HealthCare Technologies during the 4th quarter valued at approximately $28,000. Continuum Advisory LLC grew its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after buying an additional 168 shares during the last quarter. Bank of Jackson Hole Trust acquired a new stake in GE HealthCare Technologies in the fourth quarter worth $32,000. Finally, OFI Invest Asset Management bought a new stake in GE HealthCare Technologies in the fourth quarter valued at $34,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 2.0 %

GE HealthCare Technologies stock opened at $80.01 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market cap of $36.59 billion, a P/E ratio of 18.48, a P/E/G ratio of 3.19 and a beta of 1.13. The company’s fifty day simple moving average is $86.70 and its 200-day simple moving average is $85.86.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s payout ratio is presently 3.23%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on GEHC. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.